Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study
Open Access
- 13 May 2021
- journal article
- research article
- Published by Springer Nature in Dermatology and Therapy
- Vol. 11 (4) , 1277-1289
Abstract
Introduction Trimethylamine N-oxide (TMAO), a gut microbiota metabolite from dietary phosphatidylcholine, is involved in the pathogenesis of atherosclerosis and cardiovascular diseases. Psoriasis is associated with increased cardiovascular risk that is not captured by traditional biomarkers. The aim of the present study was to assess TMAO concentration in psoriasis and evaluate the relationship between TMAO and cardiovascular risk in psoriatic patients. Methods In 72 patients with psoriasis and 40 age- and sex-matched non-psoriatic controls, we evaluated fasting plasma TMAO, measured by high-performance liquid chromatography, and cardiovascular risk assessed by various scoring systems such as Framingham, QRISK2, AHA/ACC, and Reynolds risk scores. Results In patients with psoriasis, TMAO concentration was significantly higher than in the control group (195.68 [133.54–332.58] ng/ml versus 126.06 [84.29–156.88] ng/ml, respectively; p < 0.001). Plasma TMAO concentration was significantly correlated with age, total cholesterol, triglycerides, systolic and diastolic blood pressure. Furthermore, the receiver-operating characteristic (ROC) and multiple regression analysis showed that TMAO is an independent predictor of cardiovascular risk. Conclusion TMAO is a valuable candidate for biomarker and a translational link between dysbiosis and atherosclerosis in psoriasis.Keywords
Funding Information
- Ministerstwo Nauki i Szkolnictwa Wyższego (MNiSW/2020/220/DIR/NN4.)
This publication has 54 references indexed in Scilit:
- Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational StudiesJournal of the American Heart Association, 2013
- An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort studyBMJ, 2010
- The Risk of Stroke in Patients with PsoriasisJournal of Investigative Dermatology, 2009
- Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001–2002Dermatology, 2008
- Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in WomenJAMA, 2007
- Risk of Myocardial Infarction in Patients With PsoriasisJAMA, 2006
- Analgesics and cancers of the renal pelvis and ureterInternational Journal of Cancer, 1995
- Indomethacin enhances serum 2′5′-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitisJournal of Hepatology, 1994
- Treatment of an infant with severe chloramphenicol intoxication using charcoal-column hemoperfusionThe Journal of Pediatrics, 1980
- The Onset of the Diurnal Rhythm in Ovarian Cholesterol Levels in the Rat, in Relation to the Onset of Puberty and Ovarian and Uterine Weight ChangesNeuroendocrinology, 1969